Ovarian cancer cells are not known to have strong expression of Bcl-2 proteins at the time of diagnosis, and these patients initially respond favorably to chemotherapy with a 50–70% response rate [6, 7, 61, 62]. This evidence concerns the gene BCL2 and ovarian cancer.